The cell analysis global market is expected to reach $33,542.0 million by 2027 growing at a mid-single-digit CAGR from 2020 to 2027.
Cells constitute discrete units of biological function and serve as starting points in a myriad of studies to identify and map many of the basic biochemical and physical processes of life. Cell analysis is important to understand, predict, and ultimately analyze factors that underlie cell health, proliferation, function, and death by using various technologies such as PCR, Sequencing, Microfluidics, Spectrometry, Microscopes, High content analysis and others. All these technologies play a major role in gene, protein and RNA expression analysis of cells, having application in research, diagnosis and therapeutics development. Continuous advancements in technologies significantly revealed the heterogeneity, which will further enhance the cell analysis application.
The market for cell analysis is segmented based on technique, product, application, end-user and geography. The cell analysis techniques global market is segmented into PCR, Sequencing, Microfluidics and Microarrays, Spectrometry, Microscopy, Cytometry, High Content Analysis, Electrophoresis and Others. Among the techniques, the PCR segment accounted for the largest revenue in 2020 and is expected to grow at a mid-single-digit CAGR from 2020 to 2027. Microfluidics and Microarrays segment is the fastest-growing segment at a high single-digit CAGR from 2020 to 2027.
The Asia-Pacific is the fastest-growing region in the cell analysis global market at a mid single-digit CAGR from 2020 to 2027 which is attributed to the increased scope for research activities in academic & research institutes, increasing outsourcing, increased incidence of chronic diseases (cancer) and infectious disease, increasing awareness about early screening (cancer) and prenatal test and their adoption in clinical care, increasing government and private investment for - cell-based research and also for the development & expansion single-cell analysis technologies and increasing number startup companies engaged in the development innovative solutions. However, lack of technical expertise, high cost of instruments, lack of skilled labors, and large scale clinical data challenges are some of the restraints for the cell analysis market in the region.
- Agilent Technologies, Inc.
- Becton Dickinson and Company
- Bio-Rad Laboratories, Inc
- Danaher Corporation
- Illumina, Inc.
- Merck Kgaa
- Olympus Corporation
- Perkinelmer, Inc.
- Promega Corporation
- Qiagen N.V
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
1 Executive Summary
3 Market Analysis
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
126.96.36.199 Rising Incidence of Infectious and Non-Infectious Diseases and Demand for Early Detection, Diagnosis & Treatment
188.8.131.52 Increasing Government and Private Funding
184.108.40.206 Increasing Advancements in Cell Imaging Technologies Reduce the Cost and Time Consumption for the Drug Discovery Process
220.127.116.11 Growing Focus on Personalized Medicine
18.104.22.168 Introduction of Advanced Technologies in Single-Cell Analysis
22.214.171.124 Emerging Asia-Pacific Cell Analysis Market
3.3.2 Restraints & Threats
126.96.36.199 Lack of Skilled Personnel to Use Advanced Cell Analysis Instruments
188.8.131.52 Expensive Cell Analysis Instruments
184.108.40.206 Maintaining Consistency, Reproducibility of Assays and Lack of Standardization
220.127.116.11 Stringent Regulatory Framework Limits Advancements in Cellular Analysis Market
3.4 Regulatory Affairs
3.5 Funding Scenario
3.6 Cell Analysis - Deals, Acquisitions and New Product Launch
3.7 Deals and Acquisition
3.8 Technological Advancements
3.9 Porter's Five Force Analysis
3.10 Market Share Analysis by Major Players
4 Cell Analysis Global Market, by Techniques
5 Cell Analysis Global Market, by Products
6 Cell Analysis Global Market, by Application
7 Cell Analysis Global Market, by End-Users
7.2 Hospitals and Diagnostic Laboratories
7.3 Academic & Research Laboratories
7.4 Pharmaceuticals and Biotech Companies
7.5 Contract Research Organisations
7.6 Cell Banks
8 Regional Market Analysis
8.2 North America
8.5 Rest of the World
9 Competitive Landscape
9.2 New Product Launch
9.4 Agreements, Partnerships and Collaborations
10 Major Player Profiles
For more information about this report visit https://www.researchandmarkets.com/r/c65i7n